In the United States, tax exempt non-profit organizations are subject some some requirements for financial disclosure via the IRS form 990, which is available to the public. The disclosure requirements cover most U.S. based trade associations, including the Pharmaceutical Research and Manufacturers of America (PhRMA), the trade association for some 28 “member” companies.
USTR has issued an announcement for new procedures including public hearings on the 2010 Special 301 list. This is an effort to make the 301 process somewhat more open, and to provide more formal opportunities to both supporters and critics of USTR’s bilateral trade pressures to make their case. USTR’s actions are welcomed by several NGOs that have been critical of the unilateral trade pressures initiative, as it seems to provide the beginning of a more mature discussion about the objectives of trade policy, and the evidence to support different positions. Continue Reading
Written by James Love Continue Reading
Written by James Love
Tuesday, 23 October 2007
The following are comments by experts on innovation and public health, beginning with consumer and public health groups, followed by academic experts and others.
On Friday, March 16, KEI organized a briefing in the U.S. Capitol on Thailand’s recent compulsory licenses on three drugs; two for HIV/AIDS (Merck’s efavirenz (Stocrin) and Abbott’s lopinavir + ritonavir (Kaletra)) and one for heart disease (Sanofi’s clopidogrel (Plavix)). … Continue Reading
The attached is a February 24, 2005 letter signed by 162 experts, asking the World Health Organization to Evaluate New Treaty Framework for Medical Research and Development The proposal for a Medical R&D Treaty (MRDT) was designed as an alternative… Continue Reading
February 16, 2005 109th Congress, 1st Session Issue: Vol. 151, No. 17 — Daily Edition [Pages S1498-S1499] From the Congressional Record Online through the Government Publishing Office [www.gpo.gov] THE DOHA DECLARATION AND THE TRADE PROMOTION AUTHORITY ACT OF 2002 Mr.… Continue Reading
Original page: http://www.cptech.org/ip/wto/p6/zoellick02102003.doc RECEIVED 24 FEB 2003 Executive Office of the President The United States Trade Representative Washington, DC 20508 February 10, 2003 Mr. James Love Co-Chair TACD IP-workinggroup TACD Secretariat 24 Highbury Crescent UK-London N5 1RXDear Mr. Love, Thank… Continue Reading
On Monday, 12 January 2026 a division bench of the Delhi High Court comprised of Justice Hari Shankar and Justice Om Prakash Shukla approved the sale of a biosmilar version of nivolumab, a cancer drug marketed by the firm Zydus… Continue Reading
Below is a short note on good news on a court case in India concerning access to risdiplam, a treatment for spinal muscular atrophy (SMA). The note is followed by a statement on the case by Third World Network (TWN),… Continue Reading